Document is current
Any future updates will be listed below
-
Authors
Wang, Yucheng
Daddi, Alice A. https://orcid.org/0000-0001-9495-5040
Hosseini, Amir https://orcid.org/0000-0001-8229-832X
Kato, Kazuki
Khalili, Ehsan
Lindholm, Håvard T. https://orcid.org/0000-0003-4403-4387
Li, Mengjie
Wang, Yadong
Michael, David C. https://orcid.org/0009-0000-0675-6202
O’Brien, Catherine A.
De Carvalho, Daniel D.
Rehwinkel, Jan
Mehdipour, Parinaz https://orcid.org/0000-0002-4476-9925
-
Funding
Funding for this research was provided by:
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research, Oxford branch.
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 6 May 2026
First Online: 14 May 2026
Competing interests
: D.D.D. is the CSO of Adela. J.R. is a member of the scientific advisory board and a paid consultant for Avammune Therapeutics. All the other authors declare no competing interests.
